Literature DB >> 8203843

Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.

P J Wu1, K Shannon, I Phillips.   

Abstract

The susceptibility of 173 TEM-1-producing isolates of Escherichia coli was assessed by determination of MICs by the agar dilution method. MICs of amoxicillin, mezlocillin, cephaloridine, and, to a smaller extent, amoxicillin-clavulanic acid (but not cephalexin, cefuroxime, cefotaxime, ceftazidime, or imipenem) were higher for isolates that produced large amounts of beta-lactamase than for isolates that produced smaller amounts. The effect of fixed concentrations of clavulanic acid on resistance to amoxicillin was assessed for 34 selected TEM-1-producing isolates. Low concentrations of the inhibitor (0.5 to 1 microgram/ml) reduced the amoxicillin MICs substantially for almost all the isolates, although the reductions were not sufficient to render any of the isolates amoxicillin susceptible. Higher concentrations of clavulanic acid had progressively greater effects on amoxicillin MICs, but even at 8 micrograms/ml some of the isolates with high beta-lactamase activities remained resistant or only moderately susceptible to amoxicillin. All the isolates were inhibited by clavulanic acid (in the absence of amoxicillin) at concentrations of 16 to 32 micrograms/ml. TEM-1 beta-lactamase activity was inhibited in vitro by clavulanic acid, but not totally, with approximately 2% of the initial activity remaining at 2 micrograms/ml and 0.4% remaining at 8 micrograms/ml. These findings suggest that the amount of beta-lactamase activity is a major determinant of the degree of resistance to several beta-lactam antibiotics and can make the difference between susceptibility and resistance to some compounds, notably the combination of amoxicillin with clavulanic acid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203843      PMCID: PMC284486          DOI: 10.1128/AAC.38.3.494

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  beta-Lactamases of gram-negative bacteria: new challenges for new drugs.

Authors:  C C Sanders
Journal:  Clin Infect Dis       Date:  1992-05       Impact factor: 9.079

2.  Calculating MIC50.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1991-06       Impact factor: 5.790

Review 3.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

4.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

5.  Amoxycillin/clavulanate resistant Escherichia coli.

Authors:  H Williams; A King; K Shannon; I Phillips
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

6.  Amoxycillin/clavulanate resistant Escherichia coli.

Authors:  G French; T Ling
Journal:  Lancet       Date:  1988-03-26       Impact factor: 79.321

7.  Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli serotype O15.

Authors:  K Shannon; H Williams; A King; I Phillips
Journal:  FEMS Microbiol Lett       Date:  1990-02       Impact factor: 2.742

8.  Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.

Authors:  K S Thomson; D A Weber; C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

9.  Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.

Authors:  P S Seetulsingh; L M Hall; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1991-06       Impact factor: 5.790

10.  Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli.

Authors:  J A Reguera; F Baquero; J C Pérez-Díaz; J L Martínez
Journal:  J Antimicrob Chemother       Date:  1991-05       Impact factor: 5.790

View more
  22 in total

1.  TEM-103/IRT-28 beta-lactamase, a new TEM variant produced by Escherichia coli BM4511.

Authors:  Rodrigo Alonso; Guy Gerbaud; Marc Galimand; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Mature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidime.

Authors:  Laura L Bowler; George G Zhanel; T Blake Ball; Laura L Saward
Journal:  Antimicrob Agents Chemother       Date:  2012-07-09       Impact factor: 5.191

3.  TEM-168, a heretofore laboratory-derived TEM beta-lactamase variant found in an Escherichia coli clinical isolate.

Authors:  Michael R Mulvey; David A Boyd
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

4.  Inhibitor-resistant TEM (IRT) beta-lactamases with different substitutions at position 244.

Authors:  L Bret; E B Chaibi; C Chanal-Claris; D Sirot; R Labia; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

5.  Occurrence and prevalence of antibiotic resistance in landfill leachate.

Authors:  Yangqing Wang; Wei Tang; Jing Qiao; Liyan Song
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-24       Impact factor: 4.223

6.  Effects of following National Committee for Clinical Laboratory Standards and Deutsche Industrie Norm-Medizinische Mikrobiologie guidelines, country of isolate origin, and site of infection on susceptibility of Escherichia coli to amoxicillin-clavulanate (Augmentin).

Authors:  I Simpson; J Durodie; S Knott; B Shea; J Wilson; K Machka
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

7.  Characterization of pre-antibiotic era Klebsiella pneumoniae isolates with respect to antibiotic/disinfectant susceptibility and virulence in Galleria mellonella.

Authors:  Matthew E Wand; Kate S Baker; Gabriel Benthall; Hannah McGregor; James W I McCowen; Ana Deheer-Graham; J Mark Sutton
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

8.  Beta-lactam resistance in normal faecal flora from South Africa.

Authors:  P M Shanahan; C J Thomson; S G Amyes
Journal:  Epidemiol Infect       Date:  1995-10       Impact factor: 2.451

9.  Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.

Authors:  P Stapleton; P J Wu; A King; K Shannon; G French; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

10.  Role of TEM-1 β-Lactamase in the Predominance of Ampicillin-Sulbactam-Nonsusceptible Escherichia coli in Japan.

Authors:  Taro Noguchi; Yasufumi Matsumura; Toru Kanahashi; Michio Tanaka; Yasuhiro Tsuchido; Takuro Matsumura; Satoshi Nakano; Masaki Yamamoto; Miki Nagao; Satoshi Ichiyama
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.